Nature's Sunshine Products ROA 2012-2026 | NATR

Current and historical return on assets (ROA) values for Nature's Sunshine Products (NATR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Nature's Sunshine Products ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2026-06-30 $0.02B $0.26B 6.88%
2026-03-31 $0.02B $0.26B 7.29%
2025-12-31 $0.02B $0.26B 7.35%
2025-09-30 $0.02B $0.25B 5.92%
2025-06-30 $0.01B $0.25B 5.63%
2025-03-31 $0.01B $0.24B 4.10%
2024-12-31 $0.01B $0.24B 2.89%
2024-09-30 $0.02B $0.25B 6.54%
2024-06-30 $0.02B $0.24B 6.17%
2024-03-31 $0.02B $0.24B 6.58%
2023-12-31 $0.02B $0.24B 6.24%
2023-09-30 $0.01B $0.24B 3.40%
2023-06-30 $0.01B $0.23B 2.16%
2023-03-31 $0.00B $0.23B 1.74%
2022-12-31 $0.00B $0.23B 0.00%
2022-09-30 $0.01B $0.24B 4.61%
2022-06-30 $0.02B $0.24B 6.59%
2022-03-31 $0.02B $0.24B 9.06%
2021-12-31 $0.03B $0.25B 11.86%
2021-09-30 $0.02B $0.24B 9.09%
2021-06-30 $0.02B $0.24B 9.95%
2021-03-31 $0.02B $0.24B 9.59%
2020-12-31 $0.02B $0.23B 9.48%
2020-09-30 $0.02B $0.22B 7.62%
2020-06-30 $0.01B $0.22B 5.06%
2020-03-31 $0.01B $0.22B 3.73%
2019-12-31 $0.01B $0.21B 3.28%
2019-09-30 $0.00B $0.21B 1.44%
2019-06-30 $0.00B $0.20B 1.48%
2019-03-31 $0.00B $0.20B 0.00%
2018-12-31 $0.00B $0.19B -1.04%
2018-09-30 $-0.02B $0.19B -8.28%
2018-06-30 $-0.02B $0.20B -7.47%
2018-03-31 $-0.02B $0.21B -7.33%
2017-12-31 $-0.01B $0.21B -6.21%
2017-09-30 $0.00B $0.21B -1.42%
2017-06-30 $0.00B $0.21B -0.48%
2017-03-31 $0.00B $0.21B 0.95%
2016-12-31 $0.00B $0.21B 0.95%
2016-09-30 $0.01B $0.21B 6.21%
2016-06-30 $0.01B $0.21B 5.86%
2016-03-31 $0.01B $0.20B 5.95%
2015-12-31 $0.02B $0.20B 8.05%
2015-09-30 $0.01B $0.20B 4.05%
2015-06-30 $0.01B $0.20B 2.99%
2015-03-31 $0.01B $0.20B 2.97%
2014-12-31 $0.01B $0.20B 4.91%
2014-09-30 $0.02B $0.21B 7.82%
2014-06-30 $0.02B $0.20B 9.95%
2014-03-31 $0.02B $0.20B 11.51%
2013-12-31 $0.02B $0.20B 9.10%
2013-09-30 $0.02B $0.20B 10.19%
2013-06-30 $0.02B $0.20B 10.73%
2013-03-31 $0.02B $0.19B 11.49%
2012-12-31 $0.02B $0.19B 12.83%
2012-09-30 $0.03B $0.18B 15.34%
2012-06-30 $0.02B $0.18B 11.24%
2012-03-31 $0.02B $0.18B 10.72%
2011-12-31 $0.02B $0.18B 10.83%
2011-09-30 $0.01B $0.17B 5.84%
2011-06-30 $0.01B $0.17B 3.53%
2011-03-31 $0.00B $0.17B 0.60%
2010-12-31 $0.00B $0.16B -1.22%
2010-09-30 $0.00B $0.16B 1.83%
2010-06-30 $0.01B $0.16B 6.77%
2010-03-31 $0.01B $0.16B 7.42%
2009-12-31 $0.01B $0.16B 4.36%
2009-09-30 $0.00B $0.16B 1.23%
2009-06-30 $0.00B $0.16B 0.00%
2009-03-31 $0.00B $0.17B -1.81%
2008-12-31 $0.00B $0.17B -1.19%
2008-09-30 $0.00B $0.17B -1.78%
2008-06-30 $-0.01B $0.13B -3.94%
2008-03-31 $-0.01B $0.08B -7.16%
2007-12-31 $-0.01B $0.04B -19.39%
2007-09-30 $-0.02B $0.04B -40.82%
2007-06-30 $-0.01B $0.08B -11.92%
2007-03-31 $0.00B $0.11B -2.65%
2005-12-31 $0.00B $0.15B 1.99%
2005-09-30 $0.01B $0.15B 7.31%
2005-06-30 $0.01B $0.15B 8.04%
2005-03-31 $0.01B $0.15B 8.86%
2004-12-31 $0.01B $0.14B 8.41%
2004-09-30 $0.02B $0.14B 11.59%
2004-06-30 $0.01B $0.13B 7.62%
2004-03-31 $0.01B $0.13B 4.75%
2003-12-31 $0.01B $0.12B 4.10%
2003-09-30 $0.00B $0.12B 2.47%
2003-06-30 $0.01B $0.12B 5.75%
2003-03-31 $0.01B $0.12B 7.33%
2002-12-31 $0.01B $0.13B 4.78%
2002-09-30 $0.01B $0.13B 7.07%
2002-06-30 $0.01B $0.13B 7.77%
2002-03-31 $0.01B $0.13B 9.25%
2001-12-31 $0.02B $0.13B 13.23%
2001-09-30 $0.02B $0.13B 12.77%
2001-06-30 $0.02B $0.12B 13.01%
2001-03-31 $0.02B $0.12B 13.33%
2000-12-31 $0.02B $0.12B 13.50%
2000-09-30 $0.02B $0.12B 14.69%
2000-06-30 $0.02B $0.11B 15.04%
2000-03-31 $0.02B $0.11B 15.38%
1999-12-31 $0.02B $0.11B 16.59%
1999-09-30 $0.02B $0.11B 18.56%
1999-06-30 $0.02B $0.11B 20.71%
1999-03-31 $0.02B $0.11B 21.75%
1998-12-31 $0.02B $0.11B 21.90%
1998-09-30 $0.02B $0.10B 21.36%
1998-06-30 $0.02B $0.10B 20.90%
1998-03-31 $0.02B $0.10B 20.57%
1997-12-31 $0.02B $0.08B 24.05%
1997-09-30 $0.02B $0.07B 27.44%
1997-06-30 $0.02B $0.06B 34.23%
1997-03-31 $0.02B $0.04B 43.64%
1996-12-31 $0.02B $0.04B 40.72%
1996-09-30 $0.02B $0.04B 41.29%
1996-06-30 $0.01B $0.04B 38.62%
1996-03-31 $0.01B $0.04B 34.90%
1995-12-31 $0.01B $0.04B 32.00%
1995-09-30 $0.01B $0.04B 28.37%
1995-06-30 $0.01B $0.03B 26.67%
1995-03-31 $0.01B $0.03B 27.12%
1994-12-31 $0.01B $0.03B 31.37%
1994-09-30 $0.01B $0.02B 33.68%
1994-06-30 $0.01B $0.02B 34.78%
1994-03-31 $0.01B $0.02B 35.56%
1993-12-31 $0.01B $0.02B 32.18%
1993-09-30 $0.01B $0.02B 33.73%
1993-06-30 $0.01B $0.02B 35.90%
1993-03-31 $0.01B $0.02B 33.33%
1992-12-31 $0.01B $0.02B 35.29%
1992-09-30 $0.01B $0.02B 33.33%
1992-06-30 $0.00B $0.01B 29.63%
1992-03-31 $0.00B $0.01B 33.33%
1991-12-31 $0.00B $0.01B 39.02%
1991-09-30 $0.00B $0.01B 43.24%
1991-06-30 $0.00B $0.01B 47.06%
1991-03-31 $0.00B $0.01B 50.00%
1990-12-31 $0.00B $0.01B 51.61%
1990-06-30 $0.00B $0.01B 40.00%
1990-03-31 $0.00B $0.01B 42.86%
1989-09-30 $0.00B $0.01B 84.21%
1989-03-31 $0.00B $0.01B 88.89%
1988-12-31 $0.00B $0.01B 88.89%
1988-09-30 $0.00B $0.01B 88.89%
1988-06-30 $0.00B $0.00B 94.12%
1988-03-31 $0.00B $0.00B 75.00%
1987-12-31 $0.00B $0.00B 53.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.230B $0.480B
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
United Therapeutics (UTHR) United States $21.460B 17.90
Merck (MKKGY) Germany $19.487B 15.54
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.317B 19.36
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
USANA Health Sciences (USNA) United States $0.275B 15.05
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
VAXART, INC (VXRT) United States $0.117B 3.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00